Chinese researchers have reported a major breakthrough in regenerative medicine with the development of a novel mitochondrial capsule transplantation therapy that enables the efficient and safe delivery of healthy mitochondria into cells for the first time.
The study, published on Wednesday in the journal Cell, presents a new approach that could help address serious conditions linked to mitochondrial dysfunction, including Parkinson’s disease and other neurodegenerative and genetic disorders.
Mitochondria, often described as the “power plants” of cells, are responsible for converting nutrients into energy and also carry their own genetic material. Mutations in mitochondrial DNA can lead to severe diseases affecting more than one in 5,000 people worldwide.
Currently, treatments mainly focus on managing symptoms rather than repairing damaged mitochondria.
Researchers from the Guangzhou Institutes of Biomedicine and Health under the Chinese Academy of Sciences, together with Guangzhou Medical University and other institutions, developed a method using red blood cell membrane vesicles as protective “capsules” to carry healthy mitochondria.
These capsules, measuring about one-thousandth of a millimeter in diameter, protect mitochondria and allow them to pass through cellular barriers, enter cells, and integrate with existing mitochondrial networks.
The study found that the new system achieved a delivery efficiency of around 80 percent, compared to less than 5 percent for unprotected mitochondria. Once inside the cell, the transplanted mitochondria actively fused with the cell’s internal network and helped restore normal energy metabolism.
In laboratory tests using patient-derived cells with mitochondrial DNA mutations, the introduction of healthy mitochondria reduced the proportion of defective mitochondria and restored cellular energy function.
Animal experiments further demonstrated promising results. In Parkinson’s disease mouse models, delivery of mitochondrial capsules to affected brain regions prevented neuronal damage, restored mitochondrial function, and significantly improved motor abilities. In other genetic disease models, the therapy extended lifespan and alleviated multi-organ failure.
Researchers said the findings suggest that healthy organelles, including mitochondria, could potentially be used as therapeutic agents in the future, offering a new direction for treating previously incurable diseases.